Recent headlines from the sources AlphaScala monitors. AlphaScala analysis is published in the main market section.
Sarepta Therapeutics shares dropped after Q1 earnings beat expectations but 2026 revenue guidance remained unchanged. The market shift signals a growth reset.
U.S. Physical Therapy reported a -$0.12 EPS, missing by $0.61, as revenue growth failed to meet expectations. Watch for margin stabilization in Q2 filings.
Tutor Perini posted a $1.03 EPS, beating estimates by $0.07, but revenue fell short at $1.4B. Watch for whether record cash flow can sustain future growth.
DoorDash shares jumped 14% as revenue grew 33% to $3.03 billion. Investors must now weigh the company's aggressive tech spending against its mixed EBITDA outlook.
Snap shares fell 4% as the company confirmed the end of its $400M Perplexity deal and issued cautious Q2 guidance amid regional geopolitical uncertainty.
Focus Financial is moving from a high-volume acquisition model to a centralized, scale-focused strategy, with 60% of earnings now in its unified partner arm.
Voya Financial plans $150M in Q2 buybacks after returning $200M in Q1. The firm is now targeting 2% organic growth to sustain momentum in its core segments.
InMode's Q1 2026 results highlight shifting demand and margin pressures. Investors should monitor consumable growth as a key indicator of market health.
Azenta's Q2 2026 results highlight a strategic pivot following the classification of B Medical Systems as discontinued operations. Focus shifts to core margins.
Hut 8's Q1 2026 results highlight a strategic pivot toward high-performance computing infrastructure. The firm holds an Alpha Score of 62/100 as it scales.
UWM Holdings is transitioning its mortgage servicing operations in-house to improve control and margins. The next catalyst is the progress on this migration.
Apollo Global Management's Q1 2026 results highlight a focus on private credit origination and fee-related earnings. Monitor capital deployment trends.
Manitowoc's Q1 2026 earnings reveal a focus on operational discipline and cost management. Investors should watch order backlogs for future margin signals.
Cabot maintains its $6.00-$6.50 EPS guidance while targeting $22M in savings from capacity cuts. Monitor the firm's execution on these cost-reduction targets.
CS Disco (LAW) Q1 2026 results highlight a strategic pivot toward AI-driven legal tech. Investors are now watching for signs of operating leverage and growth.
PSBD's Q1 2026 earnings highlight portfolio yield and credit quality. Investors must monitor net investment income margins and leverage as the cycle shifts.
SolarEdge shares face pressure after a Q1 EPS miss despite 41% revenue growth. Investors are now focused on Q2 margin guidance to validate the turnaround.
Vertex Pharmaceuticals reports Q1 2026 earnings, balancing core cystic fibrosis strength against the need for a more aggressive M&A strategy to drive growth.
Emerson Electric is seeing a reassessment as investors distinguish between industrial automation and AI-specific hardware. EMR holds an Alpha Score of 41/100.
CVS Health faces margin pressure from rising medical utilization. With an Alpha Score of 57, the firm’s ability to reprice premiums is the key catalyst.
Berkshire Hathaway faces a valuation gap as tech-driven markets leave the conglomerate behind. With an Alpha Score of 48/100, monitor future capital moves.
GEO Group's Q1 2026 update emphasizes debt reduction over expansion. With an Alpha Score of 49, the firm's next move is to prove it can lower interest expenses.
Icahn Enterprises reported its Q1 2026 results with a focus on adjusted EBITDA. Investors should monitor the gap between non-GAAP metrics and cash flow.
LATAM Airlines Group S.A. (LTM) begins its Q1 2026 cycle with a focus on capacity management and regional demand. Monitor upcoming traffic reports for shifts.
Marriott's Q1 2026 results highlight a shift toward normalized growth. With an Alpha Score of 61, the focus is on RevPAR sustainability and capital discipline.
Ultragenyx faces a critical Q1 2026 test as it balances commercial scaling against high cash burn. Watch for revenue growth to dictate future capital needs.
Strata Critical Medical (SRTA) faces margin pressure as Q1 2026 clinical service expansion tests its cash runway. Monitor liquidity and service utilization.
Lincoln National reports Q1 earnings on May 7 with a $1.60 EPS target. Watch for margin trends and interest rate sensitivity to gauge the stock's next move.
Main Street Capital faces a critical Q1 test as investors weigh a $1.01 EPS target against rising Treasury yields and potential portfolio credit risks.
Earnings density peaks with Shell, Uber, and Arm reporting. Monitor sector-specific margin trends and forward guidance to navigate this high-volume period.